WHO ACTION

WHO ACTION. The Access to COVID-19 Tools Accelerator (ACT-A) Therapeutics Partnership, known as WHO ACTION, is a critical pillar of the international pandemic response coordinated by the World Health Organization. Launched in 2020, it specifically focuses on accelerating the development, equitable allocation, and delivery of effective COVID-19 therapeutics to low- and middle-income countries. The initiative represents a collaborative effort among global health agencies, governments, philanthropic organizations, and the private sector to address one of the most pressing needs during the COVID-19 pandemic.

Overview

WHO ACTION was established as a dedicated workstream under the broader Access to COVID-19 Tools Accelerator, a landmark global collaboration initiated by the World Health Organization, the European Commission, and the Government of France. Its creation was a direct response to the urgent need for accessible treatments alongside COVID-19 vaccines and diagnostics. The partnership operates in close coordination with other ACT-A pillars, such as the COVAX facility, and aligns with the goals of the COVID-19 Technology Access Pool. Key founding partners include Unitaid, Wellcome Trust, and the Bill & Melinda Gates Foundation, which provided crucial early-stage funding and technical expertise.

Objectives and scope

The primary objective of WHO ACTION is to ensure rapid, fair, and affordable access to life-saving COVID-19 therapeutics worldwide, with a particular emphasis on supporting health systems in the Global South. Its scope encompasses the entire therapeutic value chain, from research and development through to procurement and in-country delivery. A major focus has been on identifying and scaling up treatments like corticosteroids and specific antivirals, while also investing in novel agents and repurposed drugs. The initiative aims to mitigate severe illness and death, reduce pressure on intensive care units, and complement national vaccination campaigns led by ministries of health.

Implementation and activities

Implementation of WHO ACTION involves a multi-faceted approach coordinated from its hub at WHO headquarters in Geneva. Key activities include conducting large-scale, randomized clinical trials such as the Solidarity Trial to identify efficacious treatments, and supporting generic manufacturing through agreements with the Medicines Patent Pool. The partnership facilitates bulk procurement and coordinates logistics with organizations like the World Food Programme and UNICEF. It also provides technical assistance to countries for integrating new treatments into national COVID-19 treatment guidelines, building on the existing infrastructure of programs like the Global Fund to Fight AIDS, Tuberculosis and Malaria.

Governance and funding

Governance for WHO ACTION is provided through a steering committee that includes representatives from the World Health Organization, donor governments such as the United States and the United Kingdom, and civil society organizations. Day-to-day operations are managed by a secretariat within the WHO Health Emergencies Programme. Funding is derived from a mix of public donors, including contributions from the European Union and the Government of Germany, and major philanthropic commitments from the Wellcome Trust and the Bill & Melinda Gates Foundation. Financial coordination and reporting are often managed in collaboration with established mechanisms like the World Bank.

Impact and evaluation

The impact of WHO ACTION is measured through its contribution to the global distribution of therapeutics, particularly the deployment of millions of treatment courses of drugs like dexamethasone to over 100 countries. Independent evaluations, including those by the ACT-Accelerator Evaluation Committee, have assessed its role in strengthening therapeutic research pipelines and market shaping. The initiative's legacy is seen in its efforts to establish a more resilient global framework for equitable access to medical countermeasures, informing future preparedness for health emergencies as outlined in the International Health Regulations. Its work has been recognized in forums such as the G20 and the World Health Assembly.

Category:World Health Organization Category:COVID-19 pandemic Category:Global health initiatives